Good health is the foundation of vibrant lives and thriving communities. Thanks to decades of medical and scientific advancement, we live in a time where access to innovation means that many previously devastating diseases can be managed or even cured.
But how are we addressing the areas where challenges remain and patient needs are still unmet?
In this series, we speak with leading experts for insights into how we can unlock the medicines of tomorrow and get transformative treatments to people in as quickly as possible.
From research and development, to regulatory and approval processes, it is our belief that sharing insights on each part of the healthcare ecosystem can help transform patient experiences and outcomes.
This recording was organised and funded by Johnson & Johnson
June 2024
CP-460011
Hosted on Acast. See acast.com/privacy for more information.
Good health is the foundation of vibrant lives and thriving communities. Thanks to decades of medical and scientific advancement, we live in a time where access to innovation means that many previously devastating diseases can be managed or even cured.
But how are we addressing the areas where challenges remain and patient needs are still unmet?
In this series, we speak with leading experts for insights into how we can unlock the medicines of tomorrow and get transformative treatments to people in as quickly as possible.
From research and development, to regulatory and approval processes, it is our belief that sharing insights on each part of the healthcare ecosystem can help transform patient experiences and outcomes.
This recording was organised and funded by Johnson & Johnson
June 2024
CP-460011
Hosted on Acast. See acast.com/privacy for more information.
In this episode, we talk about the importance of shared decision-making in helping patients achieve a “life of possibility”, especially in complex illnesses like multiple myeloma.
Our experts discuss the barriers that prevent patients and HCPs from being equal partners, how shared decision-making leads to better decision-making, and the critical role of advocacy groups in empowering patients to have a greater say in their treatment pathway.
This recording was organised and funded by Johnson & Johnson
August 2025
CP-530923 | CP-530918
Hosted on Acast. See acast.com/privacy for more information.